Iteos Therapeutics Inc expected to post a loss of 99 cents a share - Earnings Preview

iTeos Therapeutics

08/05/2023 13:53

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 10
(estimated). 
    * The Watertown Massachusetts-based  company is expected to
report
 a 94.7% decrease in revenue to $8.038 million from $152.52
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Iteos Therapeutics
Inc is
for a loss of 99 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 118.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $41​, above​ its last closing price
of $14.25. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022              0.33                         
 Sep. 30 2022  0.11        0.10       0.03      Missed  -69.2
 Jun. 30 2022  1.13        1.20       0.15      Missed  -87.5​
 Mar. 31 2022  0.79        0.80       1.82      Beat    128.9
 ​​Dec.        1.84        1.28       4.89      Beat    282.6
 31 2021                                                
 Sep. 30 2021  6.09        4.95       1.86      Missed  -62.4​
 Jun. 30 2021  -0.45       -0.41      -0.75     Missed  -81.2
 Mar. 31 2021  -0.48       -0.48      -0.39     Beat    18.4
 This summary was machine generated May 8 at 12:53 GMT.  All
figures in US dollars  unless otherwise stated